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Is it Inevitable? Is it Preventable?*
John J. Lamberti, MD
San Diego, California
William I. Norwood, working at the Boston Children’s
Hospital, developed and refined a surgical procedure that
permitted babies born with hypoplastic left-heart syndrome
(HLHS) to survive and enjoy life (1). The high mortality
rates reported during the 1980s have gradually declined as
various surgeons and medical centers have refined both the
surgical techniques and the pre- and post-operative care for
infants born with HLHS. In this issue of the Journal, Porras
et al. (2) report on the treatment of aortic arch obstruction
(COA) after the Norwood procedure (NP) (2). Their report
specifically focuses on infants who underwent primary
balloon dilation (BD) of COA after the NP. Infants
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requiring surgery as the primary treatment for COA after
the NP were excluded from the analysis. The report is
notable for multiple reasons. The study group was culled
from the overall Boston Children’s Hospital NP experience
from January 1993 to May 2009. During the time period
studied, 556 patients underwent the NP at Children’s
Hospital Boston. There were 462 patients alive at 30 days
after surgery, and 133 required arch interventions (29%).
Seventeen patients were excluded from the analysis, 13
presumably underwent primary surgical treatment, and 4
patients were excluded because primary BD was performed
elsewhere or a stent was implanted. The impact of COA on
early mortality (1 month) was not examined in this
analysis.
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varied depending on the clinical findings and their conse-
quences. A strong indication for BD was defined as a
coarctation index 50% and/or a peak gradient 15 mm
Hg in the presence of normal ventricular function or a
gradient 10 mm Hg in the presence of “significant”
ventricular dysfunction. Significant ventricular dysfunction
was defined as moderate or worse ventricular dysfunction on
pre–cardiac catheterization echocardiography or evidence of
hemodynamic compromise (i.e., ventricular end-diastolic
pressure 14 mm Hg and/or calculated cardiac index 2.6
/min/m2). These indications for intervention are similar to
the criteria used for intervention for COA after the NP at
Rady Children’s Hospital San Diego.
This report is a very important contribution not only
because it emanates from the medical center where the NP
was developed and refined but also because the investigators
have provided demographic information that permits an
estimate of the overall incidence of important COA after
the NP. Recently, the Pediatric Heart Network (PHN), a
consortium of 15 North American medical centers focused
on the treatment of congenital heart disease, reported the
results of a randomized clinical trial designed to compare
shunt types after the NP for single-ventricle lesions (3).
The Boston Children’s Hospital is a member of the
PHN. In the PHN trial, 12-month survival was 73.7% in
the right ventricle–to–pulmonary artery (RVPA) shunt
group and 63.6% in the modified Blalock-Taussig (MBT)
shunt group. Of note, 4.7% of the RVPA patients required
revision of the neoaorta during the initial Norwood hospi-
talization, while 2.5% of the MBT patients required arch
interventions during the first hospitalization. In the interval
between Norwood discharge and stage II discharge, 21.5%
of the RVPA shunt patients required arch interventions,
while 18.7% of the MBT shunt patients required interven-
tions. Finally, between stage II discharge and 12 months of
age, an additional 6.8% of the RVPA shunt patients
required interventions, while 4% of the MBT shunt patients
required interventions. These findings suggest that early and
late arch obstruction occurs in a substantial number of
patients undergoing the NP at the leading institutions
focused on the treatment of patients with HLHS in North
America.
What lessons can be learned from the study by Porras et
al. (2)? The investigators looked for potential causal factors
for COA requiring intervention. They found that COA
after the NP could be categorized as proximal or distal. The
most common site of COA was distal to the left subclavian
artery (88% of patients). Fourteen patients had proximal
COA. Ten of 14 had obstructions in the transverse arch
between the origins of the innominate and left subclavian
arteries. Four patients had COA proximal to the origin of
the brachiocephalic vessels. Proximal COA was significantly
associated with shorter freedom from reintervention, reop-
eration, and transplantation-free survival. Patients with
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catheterization more often than patients with distal COA.
Symptoms due to arch obstruction also predicted a poor
outcome. Overall, BD was acutely successful in most pa-
tients. However, reintervention, either catheter based or
surgical, after primary BD for COA after NP was necessary
in many patients.
Potential surgical and technical factors associated with
COA after NP were analyzed. There was no association
between individual surgeons and patient outcomes. Some
investigators (4,5) have suggested that coarctectomy at the
time of arch reconstruction during the NP portends an
improved late outcome. In the study by Porras et al. (2),
coarctectomy at the time of the NP did not influence the
outcome of BD for late COA. In a different report from
Boston Children’s Hospital, Bautista-Hernandez et al. (6)
described outcomes in a smaller cohort of patients operated
between January 2000 and June 2005. In their report, 210
patients who underwent the NP were analyzed. Operative
mortality was 10%. The incidence of COA requiring
intervention (BD, surgical arch augmentation, or both) was
reported as 24%. Pre-operative anatomic aortic coarctation
was consistently linked to late neoaortic arch obstructions.
In the study by Bautista-Hernandez et al. (6), patients
having aortic arch repair by means of direct connection (i.e.,
coarctectomy) with or without autologous pericardium
patching at the NP were less likely to have late COA. It is
very interesting that in a somewhat different analysis of a
group of patients that included those reported by Bautista-
Hernandez et al. (6), Porras et al. (2) conclude that
coarctectomy at the time of the NP is not protective in the
subset of patients who develop late COA.
What is the take-home message of this report? First,
data from this single-center report and the PHN pooled
data indicate that the problem of late COA after the NP
has not been solved. Porras et al. (2) were not able to
identify anatomic factors that correlated with their out-
comes, including examination of the shape of the trans-
verse arch on the post-operative angiograms to determine
if unusual arch anatomy predicted late problems. There
were not enough patients with aberrant right subclavian
arteries to permit separate analysis of that subgroup.
Porras et al. do not comment on other variations in the
branching of aortic arch vessels that may be associated
with a small transverse aortic arch or the absence of an
aortic isthmus.
It is likely that late distal COA will be inevitable in a
small subset of patients undergoing NP for several reasons.
Unusual anatomy of the distal transverse arch and/or the
isthmus of the aorta, particularly in the presence of an
aberrant subclavian artery, may preclude effective coarctec-
tomy. In that situation, there may be a very narrow strip of
native tissue, and an onlay patch must be used. In addition,
it is difficult, if not impossible, to identify the entire
geography of the ductal tissue in the operating room.
Surgeons performing the NP normally use optical assistanceand visual cues to determine where ductal tissue ends and
normal aorta begins. Residual ductal tissue inadvertently
incorporated into the repair can result in progressive invo-
lution and narrowing of the distal portion of the arch
reconstruction. If this anatomic substrate is present, a subset
of patients undergoing the NP will develop distal COA
simply because it is impossible to surmount anatomic
obstacles presented by the arch configuration or the location
of ductal tissue. Late distal arch obstruction may respond
favorably to BD because the interventionalist is dilating
constricted ductal tissue rather than a circumferential sur-
gical scar. In contrast, proximal arch obstruction is prob-
ably always related to technical factors. Proximal COA
caused by an inadequate or kinked patch is less likely to
be amenable to BD. Can proximal arch obstruction
and/or transverse arch obstruction be prevented? Intra-
operative transesophageal echocardiography may not
yield satisfactory views of the ascending aorta and trans-
verse arch. If right radial and femoral or umbilical artery
pressures are routinely monitored during the NP, a
gradient noted at the completion of operation would
identify transverse arch obstruction and permit immedi-
ate revision. Passing the right atrial catheter across the
tricuspid valve and comparing right ventricular systolic
pressure with femoral or umbilical artery pressure will
permit an evaluation of all the potential areas of stenosis
after the repair. Of course, on-the-table angiography
performed in a hybrid operating room would also identify
areas of narrowing likely to become early or late COA
sites. It is also likely that identification of proximal or
distal COA immediately after NP might affect the
reported early mortality rate.
In summary, the report by Porras et al. (2) is an important
contribution because it defines an ongoing problem in the
surgical treatment of HLHS. The PHN report confirms
that the problem of early and late COA after the NP for
HLHS still occurs at the leading centers treating congenital
heart disease in North America. Fortunately, many patients
can be helped by BD or surgery. Proximal COA may be
identified and corrected at the time of NP if the post-NP
intraoperative analysis is aggressive and thorough. Although
the prevention of distal COA remains a challenge, it is
reassuring to note that in a report by Ballweg et al. (7),
reintervention for late COA did not affect short to midterm
outcomes during the staged approach to treatment of
HLHS.
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